ライフサイエンスコーパス: bone morphogenetic protein

1 olic genes such as Sox9, Col2a1, and Acan by bone morphogenetic proteins.

2 und that the extracellular metalloproteinase bone morphogenetic protein 1 (BMP-1) is involved in endo

3 en processing by the C-propeptide proteinase bone morphogenetic protein 1 (BMP-1).

4 Mutations in bone morphogenetic protein 1 (BMP1) in humans or deletio

5 ntified the secreted zinc metalloproteinase, bone morphogenetic protein 1 (BMP1), as responsible for

6 es the cleavage of C-terminal procollagen by bone morphogenetic protein 1 (BMP1).

7 C1r/C1s, urchin embryonic growth factor, and bone morphogenetic protein 1 domain indicate that Mt2I28

8 einase with thrombospondin motifs) and BMP1 (bone morphogenetic protein 1)/Tolloid-like families, res

9 The four members of the family: bone morphogenetic protein-1 (BMP-1), mammalian tolloid

10 Here we show that bone morphogenetic protein-1 (BMP1)/Tolloid (TLD)-like p

11 ts C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains (distal domains).

12 ts C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains.

13 Bone morphogenetic protein 10 (BMP10), one member of the

14 lial growth factor A (VEGFA), interleukin-2, bone morphogenetic protein-10, VEGFC, and 2 (FGF2) were

15 Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are secreted durin

16 Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are co-expressed e

17 terms of osteoblastic differentiation using bone morphogenetic protein 2 (BMP-2) added to the medium

18 ential delivery of essential growth factors, bone morphogenetic protein 2 (BMP-2) and vascular endoth

19 Parbendazole up-regulates bone morphogenetic protein 2 (BMP-2) gene expression and

20 Although bone morphogenetic protein 2 (BMP-2) is known to stimula

21 determining role of these residues, BG bound bone morphogenetic protein 2 (BMP-2) weakly or not at al

22 In calcified arteries, bone morphogenetic protein 2 (BMP-2)levels were increase

23 The expressions of bone morphogenetic protein 2 (BMP2) and BMP6; sex-determ

24 study, we discovered the double deletion of bone morphogenetic protein 2 (Bmp2) and bone morphogenet

25 Bone morphogenetic protein 2 (BMP2) in chromosomal regio

26 Bone morphogenetic protein 2 (BMP2) promotes PF formatio

27 Otic-specific knockout of bone morphogenetic protein 2 (Bmp2) results in absence o

28 e previously identified a nuclear variant of bone morphogenetic protein 2 (BMP2), named nBMP2, that i

29 Recombinant human bone morphogenetic protein 2 (rhBMP-2) is an osteoinduct

30 GO with the growth factor recombinant human bone morphogenetic protein 2 (rhBMP-2), producing a scaf

31 ated osteoblast mineralization by regulating bone morphogenetic protein 2 and p53.

32 A bone morphogenetic protein 2 gradient, presented across

33 ptide nanostructures amplified signalling of bone morphogenetic protein 2 significantly more than the

34 Bone morphogenetic protein 2-inducible kinase (BMP2K) ha

35 les, histochemical, and immunohistochemical (bone morphogenetic protein 2/4 [BMP2/4], osteocalcin [OC

36 rently, sustained in vivo delivery of active bone morphogenetic protein-2 (BMP-2) protein to responsi

37 ch as fibroblast growth factor-2 (FGF-2) and bone morphogenetic protein-2 (BMP-2) work synergisticall

38 ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoindu

39 gulates differentiation of OCs downstream of bone morphogenetic protein-2 (BMP-2)-stimulated osteobla

40 l with a collagen scaffold soaked in saline, bone morphogenetic protein-2 (BMP-2; 200 ng), 1 muM CGS2

41 al and temporal release of recombinant human bone morphogenetic protein-2 (BMP2) and vascular endothe

42 Although bone morphogenetic protein-2 (BMP2) has demonstrated ext

43 on of mesenchymal stem cells (MSCs), whereas bone morphogenetic protein-2 (BMP2) promotes osteogenic

44 The bone marrow cryogel (BMC) releases bone morphogenetic protein-2 to recruit stromal cells an

45 In osteoblasts, CypA is necessary for BMP-2 (Bone Morphogenetic Protein-2)-induced Smad phosphorylati

46 tor (RUNX)-2, integrin binding sialoprotein, bone morphogenetic protein-2, osteocalcin, and cementum

47 In the present study, bone morphogenetic protein-2/BMP-2-directed osteogenic d

48 Furthermore, bone morphogenetic protein 4 (BMP-4), which also induces

49 n of bone morphogenetic protein 2 (Bmp2) and bone morphogenetic protein 4 (Bmp4) in the dental epithe

50 response to transient (24-36 h) exposure to bone morphogenetic protein 4 (BMP4) plus inhibitors of A

51 coprotein 1 (GLG1) expression and downstream bone morphogenetic protein 4 (BMP4) signaling and also r

52 es different concentrations of activin A and bone morphogenetic protein 4 (BMP4) to polarize cells in

53 peri-gastrulation-like fate patterning upon bone morphogenetic protein 4 (BMP4) treatment of geometr

54 We show that bone morphogenetic protein 4 (BMP4), an important differ

55 We and others showed that Bone Morphogenetic Protein 4 (BMP4), and other BMPs are

56 TGF-beta signaling mediated by pSMAD2, bone morphogenetic protein 4 (BMP4), EGF, or PDGF was un

57 Consequently, bone morphogenetic protein 4 (BMP4), or ectopic expressi

58 own to promote beta-cell function, including bone morphogenetic protein 4 (BMP4).

59 Contributions of bone morphogenetic protein 4 and transforming growth fac

60 le protocol, using defined medium containing bone morphogenetic protein 4 by which human pluripotent

61 Bone morphogenetic protein 4 up-regulated alphaB-crystal

62 e, miR-18a decreased the expression of BMP4 (bone morphogenetic protein 4) and HIF-1alpha (hypoxia-in

63 ons becomes CDNF-dependent after exposure to bone morphogenetic protein 4.

64 Here, we show that bone morphogenetic protein-4 (BMP4) blocks metastasis in

65 Bone morphogenetic protein-4 (BMP4) plays a key role in

66 es for hESC differentiated to TB by means of bone morphogenetic protein-4 and inhibitors of activin A

67 t Six1 and Six2 regulate both endothelin and bone morphogenetic protein-4 signaling pathways to patte

68 nd subsequent transcriptional suppression of bone morphogenetic proteins 5 and 7.

69 Bone morphogenetic protein 6 (BMP6) contributes to the i

70 Recent work has suggested that increased bone morphogenetic protein 6 (BMP6) expression could alt

71 Lack of either bone morphogenetic protein 6 (BMP6) or the BMP corecepto

72 Bone morphogenetic protein 6 (BMP6) signaling in hepatoc

73 ether these molecules intersect in vivo with bone morphogenetic protein 6 (BMP6)/mothers against deca

74 Its expression is regulated by the bone morphogenetic protein 6 (BMP6)/SMAD1/5/8 pathway an

75 ivary gland fluid secretion, is regulated by bone morphogenetic protein 6.

76 ansforming growth factor beta (TGFbeta), and bone morphogenetic protein 7 (BMP7), CD1c(+) dendritic c

77 We further identify bone morphogenetic protein 7 as one of them.

78 8 also increased renal expression of klotho, bone morphogenetic protein 7, and Smad7.

79 VEGF-A, VEGF-C, VEGF-D, VEGF-A isoform 121, bone morphogenetic protein 7, macrophage colony-stimulat

80 sue into endocrine cell types by exposure to bone morphogenetic protein 7.

81 (drMM) in the presence of human recombinant bone morphogenetic protein 7/human recombinant fibroblas

82 hat supplementation of exogenous recombinant bone morphogenetic proteins 7 effectively ameliorates en

83 echanisms involved revealed the induction of bone morphogenetic protein-7 (BMP7) expression, a critic

84 We evaluated the effects of THR-184, a bone morphogenetic protein-7 agonist, in patients at hig

85 cluding fibroblast growth factor 21 (FGF21), bone morphogenetic protein 8b (BMP8b), growth differenti

86 d endothelial cell signalling in response to bone morphogenetic protein 9 (BMP9) and BMP10 is of sign

87 Bone morphogenetic protein 9 (BMP9) is a circulating fac

88 Circulating bone morphogenetic protein 9 (BMP9), a vascular quiescen

89 T is caused by loss-of-function mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signa

90 r-like kinase 1 (ALK1), endoglin, Smad4, and bone morphogenetic protein 9 (BMP9).

91 BMP9 (bone morphogenetic protein 9) is a circulating endotheli

92 recipitation-sequencing experiments on BMP9 (bone morphogenetic protein 9)-stimulated endothelial cel

93 Bone morphogenetic proteins 9 and 10 (BMP9/BMP10) are ci

94 ENG (endoglin) is a coreceptor for BMP (bone morphogenetic protein) 9/10 and is strongly express

95 Bone morphogenetic protein-9 (BMP-9) is a circulating cy

96 Our objective is to determine circulating Bone morphogenetic protein-9(BMP-9) levels in subjects w

97 T signaling did not significantly affect the bone morphogenetic protein activity.

98 We found an interaction between WNT, bone morphogenetic protein and hedgehog signalling with

99 otein negatively regulates the activities of bone morphogenetic protein and phosphoinositide 3-kinase

100 To address whether elevated activities of bone morphogenetic protein and PI3K/AKT signaling pathwa

101 valves demonstrated activation of canonical bone morphogenetic protein and Wnt/beta-catenin signalin

102 ntiation and new bone formation through WNT, bone morphogenetic protein, and Notch signaling pathways

103 ation of Hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling in the gen

104 , Indian hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling pathways i

105 cardiogenic fate of CNC(kit) is regulated by bone morphogenetic protein antagonism, a signaling pathw

106 expression of the gene encoding mesenchymal bone morphogenetic protein antagonist, GREM1.

107 ase inhibitors, activin traps, hepcidin, and bone morphogenetic protein antagonists in treating cance

108 BMP9 and BMP10 (bone morphogenetic protein) are known to regulate endoth

109 The BMPs (bone morphogenetic proteins) are essential morphogens in

110 itions and vascular calcification, including bone morphogenetic protein (BMP) and transforming growth

111 We found that modulation of bone morphogenetic protein (BMP) and WNT signaling combi

112 t in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like

113 We have recently shown that the bone morphogenetic protein (BMP) antagonist Gremlin 2 (G

114 cted gene aberrant in neuroblastoma (DAN), a bone morphogenetic protein (BMP) antagonist we detected

115 e that CHRDL1 encodes Ventroptin, a secreted bone morphogenetic protein (BMP) antagonist, the molecul

116 Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor.

117 The bone morphogenetic protein (Bmp) family of secreted mole

118 The Bone Morphogenetic Protein (BMP) family reiteratively si

119 evelopment, with a classic example being the bone morphogenetic protein (BMP) gradient's conserved ro

120 Here we show that bone morphogenetic protein (BMP) growth factor signaling

121 iron homeostasis by direct interaction with bone morphogenetic protein (BMP) ligands to induce hepci

122 that injury stimulates the production of two bone morphogenetic protein (BMP) ligands, Dpp and Gbb, w

123 equencing (ChIP-seq) data, we identified the bone morphogenetic protein (BMP) pathway as a potential

124 Here we demonstrate that the bone morphogenetic protein (BMP) pathway can also be reg

125 The bone morphogenetic protein (BMP) pathway is essential fo

126 At diagnosis, deregulation of the bone morphogenetic protein (BMP) pathway is involved in

127 in particular the dual modulation of Wnt and bone morphogenetic protein (BMP) pathway signaling, this

128 on the transforming growth factor (TGF)-beta/bone morphogenetic protein (BMP) pathway, which is one o

129 ess of endodermal development, including the Bone morphogenetic protein (Bmp) pathway.

130 ransforming growth factor beta (TGFbeta) and bone morphogenetic protein (BMP) pathways.

131 Beta-catenin/Tcf and the TGF-beta bone morphogenetic protein (BMP) provide critical molecu

132 its surrogate surface marker P2RY1, and the bone morphogenetic protein (BMP) receptor 1A (BMPR1A)/ac

133 The bone morphogenetic protein (BMP) receptor Tkv localizes

134 ated that OA-MSC expressed the same level of Bone Morphogenetic Protein (BMP) Receptor-1A as OAC but

135 14-17 of CRIM1 (cysteine-rich transmembrane bone morphogenetic protein (BMP) regulator 1).

136 ransforming growth factor beta (TGFbeta) and bone morphogenetic protein (BMP) signal transduction in

137 red neogenic hair follicles, which triggered bone morphogenetic protein (BMP) signaling and then acti

138 cal and genetic epistasis studies identified bone morphogenetic protein (BMP) signaling as a mediator

139 To assess whether bone morphogenetic protein (BMP) signaling contributes t

140 We showed previously that SMOC inhibits bone morphogenetic protein (BMP) signaling downstream of

141 Loss of the growth-suppressive effects of bone morphogenetic protein (BMP) signaling has been demo

142 mice were carried out to assess the role of bone morphogenetic protein (BMP) signaling in psoriatic

143 lly cryptic "secondary cells." Inhibition of bone morphogenetic protein (BMP) signaling in secondary

144 result of differential regulation of Wnt and bone morphogenetic protein (BMP) signaling in these two

145 Bone morphogenetic protein (BMP) signaling is critical i

146 has been constructed and, here, we show that bone morphogenetic protein (BMP) signaling is essential

147 Bone morphogenetic protein (BMP) signaling is known to c

148 Here we show that hippocampal bone morphogenetic protein (BMP) signaling is modulated

149 function of an activity-dependent autocrine Bone Morphogenetic Protein (BMP) signaling pathway at th

150 The bone morphogenetic protein (BMP) signaling pathway compr

151 ibit Ras signaling and may also activate the bone morphogenetic protein (BMP) signaling pathway in co

152 coagulation factor fibrinogen activates the bone morphogenetic protein (BMP) signaling pathway in ol

153 Hepcidin expression is induced via the bone morphogenetic protein (BMP) signaling pathway that

154 In the anterior, it activates the bone morphogenetic protein (BMP) signaling pathway throu

155 rates that RNAi silencing of a member of the Bone Morphogenetic Protein (BMP) signaling pathway, Deca

156 f these mutants target the components of the Bone Morphogenetic Protein (BMP) signaling pathway, reve

157 Bone morphogenetic protein (BMP) signaling pathways cont

158 axis is established and patterned by Wnt and bone morphogenetic protein (BMP) signaling pathways, res

159 e through modulation of Hedgehog, Notch, and bone morphogenetic protein (BMP) signaling pathways.

160 A morphogen gradient of Bone Morphogenetic Protein (BMP) signaling patterns the

161 Bone morphogenetic protein (BMP) signaling performs mult

162 between transforming growth factor beta1 and bone morphogenetic protein (BMP) signaling plays an impo

163 The family of TGF-beta and bone morphogenetic protein (BMP) signaling proteins has

164 he transforming growth factor beta (TGFbeta)/bone morphogenetic protein (BMP) signaling system.

165 Bone morphogenetic protein (BMP) signaling was activated

166 y element-binding protein (SREBP) signaling, bone morphogenetic protein (BMP) signaling, and glycosyl

167 SMAD1/5 transcription factors, activated by bone morphogenetic protein (BMP) signaling, are major re

168 Multiple invasion pathways including EMT, bone morphogenetic protein (BMP) signaling, chemokine si

169 Although antagonists of bone morphogenetic protein (BMP) signaling, such as Nogg

170 elf-renewing SCs, Foxc1 activates Nfatc1 and bone morphogenetic protein (BMP) signaling, two key mech

171 per, notable for roles in Wingless (Wnt) and bone morphogenetic protein (BMP) signaling, were differe

172 es Wnt and Notch signaling while suppressing bone morphogenetic protein (BMP) signaling.

173 , and R-spondin signaling with inhibition of bone morphogenetic protein (BMP) signaling.

174 TGF-beta and activin signals while enhancing bone morphogenetic protein (BMP) signaling.

175 and TSP-14, function redundantly to promote bone morphogenetic protein (BMP) signaling.

176 al in the Drosophila ovary where it enhances bone morphogenetic protein (BMP) signaling.

177 function, and their dysregulating effect on bone morphogenetic protein (BMP) signaling.

178 nd transforming growth factor-beta (TGFbeta)/bone morphogenetic protein (BMP) signalling and illustra

179 wingless-related integration site (WNT), and bone morphogenetic protein (BMP) signalling interactions

180 es from a murine myeloma model, we find that bone morphogenetic protein (BMP) signalling is upregulat

181 n coupled fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) signalling together wit

182 s myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling, we discover

183 process enhanced by mating and controlled by bone morphogenetic protein (BMP) signalling.

184 pression and signaling are up-regulated, and bone morphogenetic protein (BMP) signals are impaired.

185 In the Drosophila ovarian germline, Bone Morphogenetic Protein (BMP) signals released by nic

186 and Wnt/beta-catenin) or share (TGFbeta and bone morphogenetic protein (BMP)) core signaling compone

187 wingless-integrated site (Wnt)/beta-catenin, bone morphogenetic protein (Bmp), and fibroblast growth

188 This data shows that Wnt, bone morphogenetic protein (BMP), and fibroblast growth

189 ys, epidermal growth factor receptor (EGFR), bone morphogenetic protein (BMP), Jun kinase (JNK), JAK/

190 dels commonly increase signaling of the Wnt, bone morphogenetic protein (BMP), or Ras/ERK pathways, c

191 FE) is specified by sequential inhibition of bone morphogenetic protein (BMP), transforming growth fa

192 ial cells (recell-dTBs); 3) dTBs seeded with bone morphogenetic protein (BMP)-2 (dTB-BMPs); and 4) fr

193 Bone morphogenetic protein (BMP)-2 is used clinically fo

194 owth factor (TGF)-beta family, TGF-beta1 and bone morphogenetic protein (BMP)-2, in synovial fibrobla

195 s of inducible nitric oxide synthase (iNOS), bone morphogenetic protein (BMP)-2, matrix metalloprotei

196 nd that iSMCs from HGPS donors overexpressed bone morphogenetic protein (BMP)-4, which plays a key ro

197 The bone morphogenetic protein (BMP)-Smad signaling pathway

198 The bone morphogenetic protein (BMP)-SMAD signaling pathway

199 receptor and function as coreceptors for the bone morphogenetic protein (BMP)/growth differentiation

200 mone hepcidin, which is regulated by hepatic bone morphogenetic protein (BMP)/SMAD signalling.

201 ad2/3 pathway and activation of the parallel bone morphogenetic protein (BMP)/Smad1/5 axis (recently

202 was accompanied by changes in expression of bone morphogenetic protein (BMP)/sons of mothers against

203 ymatic activity, and six were members of the bone morphogenetic protein (BMP)/TGF-beta pathway.

204 es the gene encoding hepcidin (HAMP) via the bone morphogenetic protein (BMP)6 signaling to SMAD.

205 Bone morphogenetic protein (BMP)9 is a circulating growt

206 Exogenous bone morphogenetic proteins (Bmp) are well known to indu

207 f CR-CSCs to chemotherapy and the ability of bone morphogenetic proteins (BMP) to promote colonic ste

208 An activating bone morphogenetic proteins (BMP) type I receptor ACVR1

209 Bone morphogenetic proteins (BMP), part of the TGFbeta s

210 decapentaplegic (dpp), the homolog of human bone morphogenetic proteins BMP2 and BMP4, is a muscle-s

211 Bone morphogenetic proteins BMP2 and BMP6 play key roles

212 d that mutations in the type II receptor for bone morphogenetic protein (BMPRII) underlie the majorit

213 thelial serine-threonine kinase receptor for bone morphogenetic proteins (BMPs) 9 and 10.

214 glands are specified by mesenchymal-derived bone morphogenetic proteins (BMPs) and fibroblast growth

215 Bone morphogenetic proteins (BMPs) are growth factors th

216 Bone morphogenetic proteins (BMPs) are important mediato

217 Bone morphogenetic proteins (BMPs) are members of the TG

218 Bone morphogenetic proteins (BMPs) are multifunctional c

219 Bone morphogenetic proteins (BMPs) are secreted cytokine

220 Bone morphogenetic proteins (BMPs) are secreted growth f

221 Bone morphogenetic proteins (BMPs) are secreted ligands

222 Bone morphogenetic proteins (BMPs) are secreted proteins

223 Bone morphogenetic proteins (BMPs) are TGF-beta family m

224 Since the discovery of bone morphogenetic proteins (BMPs) as pluripotent cytoki

225 Subsequent treatment with bone morphogenetic proteins (BMPs) enhanced differentiat

226 the K19/14 sites in the promoter regions of bone morphogenetic proteins (BMPs) genes, which were ass

227 trauma with an osteo-inductive agent such as bone morphogenetic proteins (BMPs) has been considered a

228 gnaling involves binding to and sequestering bone morphogenetic proteins (BMPs) in the extracellular

229 In Xenopus laevis, bone morphogenetic proteins (Bmps) induce expression of

230 rcomes the inhibitory effect of lung-derived bone morphogenetic proteins (BMPs) on self-renewal and t

231 Bone Morphogenetic Proteins (BMPs) pattern the dorsal-ve

232 Bone morphogenetic proteins (BMPs) play key roles in the

233 Bone morphogenetic proteins (BMPs) regulate diverse cell

234 anoid cultures, such as those involving Wnt, bone morphogenetic proteins (BMPs), Notch, and Hedgehog

235 ignaling by Sonic hedgehog (SHH) followed by Bone morphogenetic proteins (BMPs), regulate a dynamic e

236 ly includes TGFbeta, activins, inhibins, and bone morphogenetic proteins (BMPs).

237 fferentiate into preosteoblasts that produce bone morphogenetic proteins (BMPs).

238 operate locally (e.g., Wingless/Ints [Wnts], Bone Morphogenetic Proteins [BMPs], and Hedgehogs [Hhs])

239 channels regulate release of the Drosophila bone morphogenetic protein Dpp in the developing fly win

240 ignaling pathways, including Sonic hedgehog, bone morphogenetic protein, fibroblast growth factor, tr

241 Decapentaplegic, a homolog of the vertebrate bone morphogenetic protein) from the wing imaginal disc.

242 show that the bone morphogenetic protein gradient is decoded through f

243 el, calcium deposition and the expression of bone morphogenetic protein isoform (BMPs).

244 ilarly, wild-type (WT) animals, in which the bone morphogenetic protein-mothers against decapentapleg

245 niche signalling pathways, specifically Wnt, bone morphogenetic protein, Notch and epidermal growth f

246 Treatment with bone morphogenetic protein or SHH pathway inhibitors dec

247 GDF7 (rs3072), which encodes a ligand in the bone morphogenetic protein pathway, and TBX5 (rs2701108)

248 We analyzed the effect of Irf8 on TGF-beta/bone morphogenetic protein pathway-specific genes in DCs

249 /or cocaine due to severe down-modulation of bone morphogenetic protein receptor (BMPR) axis: the ant

250 ce suggests that serotonin, mutations in the bone morphogenetic protein receptor (BMPR) II gene, and

251 e mutations leading to reduced expression of bone morphogenetic protein receptor (BMPR) II, these mut

252 Monoallelic mutations in the gene encoding bone morphogenetic protein receptor 2 ( Bmpr2) are the m

253 The effect of a mutation in the bone morphogenetic protein receptor 2 (BMPR2) gene on ri

254 Because decreased expression and function of bone morphogenetic protein receptor 2 (BMPR2) is observe

255 terized by endothelial dysfunction, impaired bone morphogenetic protein receptor 2 (BMPR2) signaling,

256 hat in SMC and EC contact cocultures, BMPR2 (bone morphogenetic protein receptor 2) is required by bo

257 with hyperactivating mutations of the type I bone morphogenetic protein receptor ACVR1 (Activin type

258 However, transforming growth factor beta and bone morphogenetic protein receptor II signaling, and hy

259 role of transforming growth factor beta and bone morphogenetic protein receptor II signaling, human

260 ifferential transforming growth factor beta, bone morphogenetic protein receptor II signaling, or car

261 CLIC4 reduced BMPRII (bone morphogenetic protein receptor II) expression and s

262 tion of SMAD1 by activin A receptor type 1L, bone morphogenetic protein receptor type 1A, and bone mo

263 morphogenetic protein receptor type 1A, and bone morphogenetic protein receptor type 1B and phosphor

264 Expression of bone morphogenetic protein receptor type 2 (BMPR2) and i

265 erozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) are t

266 ith heritable PAH caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene

267 l hypertension with germline mutation in the bone morphogenetic protein receptor type 2 (BMPR2) gene,

268 despite clinical and molecular similarity to bone morphogenetic protein receptor type 2 mutation-asso

269 BMPR2 (bone morphogenetic protein receptor type 2) mutations ac

270 Mutations in the gene encoding the bone morphogenetic protein receptor type II (BMPR2) are

271 n PASMCs from PAH patients with mutations in bone morphogenetic protein receptor type II.

272 duced aggregation; 2) rs11202221, in BMPR1A (bone morphogenetic protein receptor type1A), replicated

273 sed to track the expression of a manipulated bone morphogenetic protein receptor within the Brainbow

274 in accumulation of synaptic growth-promoting bone morphogenetic protein receptors in the cell body an

275 s of VBA, with and without recombinant human bone morphogenetic protein (rhBMP)-2, under space-making

276 In addition, the reduction in bone morphogenetic protein signaling and Shotgun express

277 However, inhibition of bone morphogenetic protein signaling caused a significan

278 G85R) We found cell-autonomous activation of bone morphogenetic protein signaling in proprioceptor se

279 ith our demonstration that the activation of bone morphogenetic protein signaling in proprioceptors a

280 n-regulatory hormone that is induced via the bone morphogenetic protein signaling pathway.

281 (Wnt), transforming growth factor-beta, and bone morphogenetic protein signaling pathways affect car

282 rse transcriptional programs associated with bone morphogenetic protein signaling, alveolar specifica

283 R/MEK/Erk1/2 signaling and downregulation of bone morphogenetic protein signaling, with negative and

284 ed either by erythroferrone or by inhibiting bone morphogenetic protein signaling.

285 onic axis depends on a morphogen gradient of Bone Morphogenetic Protein signaling.

286 dysregulated transforming growth factor beta/bone morphogenetic proteins signaling and that this imba

287 ing, and that ligandless activity in the TGF/bone morphogenetic proteins signaling pathway contribute

288 BMP (bone morphogenetic protein) signaling activity is precis

289 tor cyclin-dependent kinase 1 decreases BMP (bone morphogenetic protein) signaling activity specifica

290 ving hemojuvelin and other components of the bone morphogenetic protein-signaling pathway.

291 ay), and that they activate cardioprotective bone-morphogenetic-protein signalling in cardiomyocytes.

292 ar stress driven and downstream of canonical bone morphogenetic protein-SMAD signaling.

293 showed that loss of PEAT modestly increases bone morphogenetic protein target gene expression and al

294 es with sLR11 inhibits thermogenesis via the bone morphogenetic protein/TGFbeta signalling pathway an

295 fferentially expressed genes were related to bone morphogenetic protein type 2 receptor (BMPR2) signa

296 ty of HPAH patients inherit mutations in the bone morphogenetic protein type 2 receptor gene (BMPR2),

297 DNA damage and impaired signaling of BMPR2 (bone morphogenetic protein type 2 receptor) via two down

298 Mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ar

299 Heterozygous germ-line mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ge

300 GDF2 encodes the circulating BMP (bone morphogenetic protein) type 9, which is a ligand fo